# reload+after+2024-01-21 07:46:58.018897
address1§Building 1
address2§Suite 100 41 Seyon Street
city§Waltham
state§MA
zip§02453
country§United States
phone§781 250 0111
fax§781 250 0115
website§https://www.repligen.com
industry§Medical Instruments & Supplies
sector§Healthcare
longBusinessSummary§Repligen Corporation develops and commercializes bioprocessing technologies and systems for use in biological drug manufacturing process in North America, Europe, the Asia Pacific, and internationally. It offers Protein A ligands that are the binding components of Protein A affinity chromatography resins; and cell culture growth factor products. The company's chromatography products include OPUS pre-packed chromatography columns, which are used in the purification of biologics; and OPUS smaller-scale columns that are used in the high throughput process development screening, viral clearance validation studies, and scale down validation of chromatography processes. It also offers ELISA test kits; and chromatography resins under the CaptivA brand. In addition, the company provides filtration products, such as XCell Alternating Tangential Flow systems that are filtration devices used in upstream perfusion and cell culture processing; TangenX flat sheet cassettes, which are used in downstream biologic drug concentration, buffer exchange, and formulation processes; KrosFlo tangential flow filtration and tangential flow depth filtration systems; Spectra/Por laboratory and process dialysis products, and ProConnex TFDF flow paths. Further, it provides process analytics products, such as slope spectroscopy systems under the SoloVPE, FlowVPE, and FlowVPX brands. The company sells its products to life sciences, biopharmaceutical, and diagnostics companies; laboratory researchers; and contract manufacturing organizations. Repligen Corporation has collaboration agreements with Navigo Proteins GmbH to develop multiple affinity ligands. Repligen Corporation was incorporated in 1981 and is headquartered in Waltham, Massachusetts.
fullTimeEmployees§2025
companyOfficers§[{'maxAge': 1, 'name': 'Mr. Anthony J. Hunt', 'age': 59, 'title': 'CEO & Director', 'yearBorn': 1964, 'fiscalYear': 2022, 'totalPay': 1590440, 'exercisedValue': 9432372, 'unexercisedValue': 25221964}, {'maxAge': 1, 'name': 'Mr. James R. Bylund', 'age': 59, 'title': 'Chief Operating Officer', 'yearBorn': 1964, 'fiscalYear': 2022, 'totalPay': 820264, 'exercisedValue': 292130, 'unexercisedValue': 149960}, {'maxAge': 1, 'name': 'Ms. Christine  Gebski', 'age': 54, 'title': 'Senior Vice President of Filtration & Chromatography', 'yearBorn': 1969, 'fiscalYear': 2022, 'totalPay': 625759, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Mr. Ralf  Kuriyel', 'age': 64, 'title': 'Senior Vice President of Research & Development', 'yearBorn': 1959, 'fiscalYear': 2022, 'totalPay': 661749, 'exercisedValue': 814229, 'unexercisedValue': 33284}, {'maxAge': 1, 'name': 'Mr. Olivier  Loeillot', 'title': 'President & Chief Commercial Officer', 'fiscalYear': 2022, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Mr. Jason K. Garland', 'age': 49, 'title': 'Chief Financial Officer', 'yearBorn': 1974, 'fiscalYear': 2022, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Mr. Keith Lee Robinson', 'title': 'Chief Information Officer', 'fiscalYear': 2022, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Ms. Sondra S. Newman', 'title': 'Global Head of Investor Relations', 'fiscalYear': 2022, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Ms. Kimberly A. Cornwell', 'title': 'General Counsel', 'fiscalYear': 2022, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Dr. Jaime M. Humara Ph.D.', 'title': 'Senior Vice President of Marketing', 'fiscalYear': 2022, 'exercisedValue': 0, 'unexercisedValue': 0}]
auditRisk§5
boardRisk§3
compensationRisk§4
shareHolderRightsRisk§1
overallRisk§2
governanceEpochDate§1704067200
compensationAsOfEpochDate§1672444800
maxAge§86400
priceHint§2
payoutRatio§0.0
beta§1.034
priceToSalesTrailing12Months§14.306793
currency§USD
dateShortInterest§1702598400
forwardEps§1.77
pegRatio§-15.92
exchange§NMS
quoteType§EQUITY
shortName§Repligen Corporation
longName§Repligen Corporation
firstTradeDateEpochUtc§515165400
timeZoneFullName§America/New_York
timeZoneShortName§EST
uuid§d36d3b5f-a0ea-3415-a0a5-3856f28cb663
gmtOffSetMilliseconds§-18000000
targetHighPrice§211.0
targetLowPrice§148.0
targetMeanPrice§184.92
targetMedianPrice§185.0
recommendationMean§1.9
recommendationKey§buy
numberOfAnalystOpinions§12
quickRatio§2.028
earningsGrowth§-0.549
grossMargins§0.50167
ebitdaMargins§0.21518
trailingPegRatio§None
